Shown to be 2x more effective than traditional silicone cream in clinical studies
Read our latest publications in
AESTHETIC SURGERY JOURNAL


Skinuva™ Scar provides the most advanced topical scar therapy yet to be formulated

Skinuva™ scar is a physician-designed and clinically tested scar therapy that uses highly selective growth factors within a silicone cream matrix to help improve the appearance of scars. Our rigorous clinical studies have shown that Skinuva™ Scar improves the appearance of scars nearly two-times better when compared to regular silicone cream.
Watch this animation to see how Skinuva™ Scar is the most advanced scar cream yet to be formulated.

  • Skinuva Scar is the only scar cream that uses selective growth factors

  • Lack of advancements in scar creams for nearly 20 years until now
  • Incredible results with Skinuva Scar
Safe to be used on all skin types • Dermatologist tested • Safe to use around eyes • Free of color additives and fragrances • Not tested on animals • Contains • synthetic growth factors and other natural ingredients • No dyes • No oils • No parabens

Doctor Testimonials

Daniel Barrett MD,
Board Certified Plastic Surgeon
"I do a lot of plastic surgery; I do a lot of meticulous closures and our incisions look great, but after they heal we need to use a scar management product to help the scars heal even better after everything is closed up. One of the products that I like to use is Skinuva Scar Gel. Skinuva Scar Gel is the only product with silicone [which we know works] and growth factors that both lighten the scar and additionally improve the appearances of the scar. Actually, we see 73% improvement at 3 months- nothing else on the market has such a high rating. Patients love it and we make sure to provide it for all of our patients. We highly recommend Skinuva."
Daniel Barrett MD,
Board Certified Plastic Surgeon
Nima Shemirani MD,
Board Certified Facial Plastic Surgeon
"This 19-year-old patient underwent reconstruction from a skin cancer in her upper lip. I was very worried about the outcome of this case because this patient was so young. My main goal was to close the wound as best as possible and plan to do a secondary scar revision about 1 year later. I had started this patient on Skinuva approximately 1 month after the reconstruction and the patient used it faithfully for the next 9 months. I also did perform microneedling sessions every 6-8 weeks to help the scar. At her 10 month follow up, her scar was literally invisible. I was shocked because she was coming in for planning of the second stage of scar revision, and it was no longer necessary. She even asked her new roommate what she thought of her scar, and her roommate replied, "What scar?" This case is very special and I was so happy that Skinuva helped her heal better."
Nima Shemirani MD,
Board Certified Facial Plastic Surgeon